Clinical Trial Update: Prebiotic Galacto-oligosaccharide and Acute GVHD [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating galacto-oligosaccharide as a prebiotic for acute graft-versus-host disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Galacto-oligosaccharide (galacto-oligosaccharide)

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Acute GVHD | Phase 1, Phase 2 | Status: RECRUITING